0 items USD 0.00Search
Your search for "current partnering immunomedics partnering deals alliances 2010 2016" gave back 22 results.
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
Catalog:
La Merie Publishing
November 2022
Price: USD 2,500.00
Artificial Intelligence For Drug Discovery, Biomarker Development and Advanced R&D Landscape Overview Q2/2018 offers comprehensive coverage of...
Catalog:
DKA
August 2018
Price: USD 4,000.00
“Lutetium-177 Global Market Analysis” gives comprehensive insights on the various Lu-177 based drugs being developed for the treatment of GEP-NET,...
IQ4I
February 2020
Price: USD 3,600.00
Retinoic acid-related orphan nuclear receptor gamma (RORgamma) is a hot, but „difficult-to-drug“ target. More than 30 companies are active in drug...
Catalog:
La Merie Publishing
February 2016
Price: USD 1,050.00
Over the last two decades, the Pharmaceutical/Biotech industry has undergone radical changes. The unprecedented downsizing of the internal discovery...
Catalog:
IQ4I
January 2016
Price: USD 15,000.00
“Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH...
IQ4I
October 2019
Price: USD 3,600.00
“Nonalcoholic steatohepatitis (NASH) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of NASH...
Catalog:
IQ4I
July 2015
Price: USD 3,600.00
Over the last two decades, the Pharmaceutical industry has seen a radical change. The unprecedented downsizing of the internal discovery of big...
Catalog:
IQ4I
May 2021
Price: USD 7,200.00
The Global Drug Abuse Testing devices market is accounted for $ 3856.3 million in 2017 and is expected to reach $ 7149.5 million by 2026 growing at a...
Catalog:
Stratistics MRC
April 2018
Price: USD 4,150.00
The Global Small Molecule Drug Discovery Market is expected to grow at a CAGR of 8.5% during the forecast period. Some of the factors such as rise in...
Catalog:
Stratistics MRC
December 2018
Price: USD 4,150.00
COVID-19 Vaccines - Mass Rollouts begin but hurdles are halting progress Summary 2021 has started tougher than many expected with new variants...
MarketLine
January 2021
Price: USD 995.00
The Competitive Intelligence Report Inhibitors of the bromodomain and extra-terminal domain (BET) family as of January 201 provides a competitor...
Catalog:
La Merie Publishing
January 2016
Price: USD 225.00
A generic drug is a pharmaceutical product, usually intended to be interchangeable with an innovator product, that is manufactured without a license...
Catalog:
Signals and Systems Telecom
February 2015
Price: USD 2,500.00
The Competitive Intelligence report about Nonalcoholic Steatohepatitis (NASH) - Novel Drug Candidates provides a competitor analysis in the...
Catalog:
La Merie Publishing
January 2015
Price: USD 249.00
North America drug discovery market is expected to grow by 7.9% annually in the forecast period and reach $41.44 billion by 2030 driven by the rising...
Catalog:
Grace Market Data
November 2021
Price: USD 2,700.00
